The dynamics of the Philips Respironics recall (WSJ: Roland, D, 8/17/21) requires all sleep physicians to consider non-CPAP therapies for patients diagnosed with Obstructive Sleep Apnea (OSA). The timeline for Philips to rectify their situation due to foam degradation and its consequences is unknown. Currently, ResMed PAP related devices are on backlog. Additionally, many of the 3 million patients affected by this recall may be reluctant to try CPAP again or simply prefer alternative treatment.
Read More